Categorized | Business, Health

CVS Announces Seniors' Event

CVS on East High Street.

CVS on East High Street.

LOWER POTTSGROVE PA – A program designed to teach Pennsylvania senior citizens how to better manage their medications and save money on prescription drugs is being sponsored by the CVS Pharmacy chain that operates two stores within the township, but the closest the program will get to this area is Harleysville.

CVS said Monday (June 29, 2009) it would join the National Council on Aging in presenting “Pack Your Bag” outreach events this summer, to which seniors are invited to pack a bag with all their medications and bring them for a consultation with pharmacists. The “Pack Your Bag” session closest to Sanatoga is scheduled July 22 at the Harleysville (PA) Senior Center, 14 miles northeast of the village.

Eight in 10 older Americans have at least one chronic health problem, such as high blood pressure or diabetes, according to CVS, and 50 percent of participants in federal Medicare Part D drug plans regularly take an average of eight or more prescriptions. Rising costs and the potential of adverse drug interactions both pose problems for seniors, the company said.

Since the program began last year, CVS said it found that 7 percent of seniors were taking expired medications; 15 percent were not taking medications as prescribed; 10 percentĀ  were at risk for potential drug interactions; and 15 percent had the opportunity to switch to money-saving generic drugs.

Eighteen “Pack Your Bag” events are scheduled statewide between July 7 and August 24. In Lower Pottsgrove, CVS operates stores on East High Street and North Charlotte Street.

Sign up to get The Sanatoga Post delivered free daily by e-mail.
Got news for us? E-mail The Post.

Share

One Response to “CVS Announces Seniors' Event”

Trackbacks/Pingbacks

  1. [...] stores within the township , but the closest the program will get to this area is Harleysville . Read More here Share and [...]


From Our Sponsors

RSS Health News

  • FDA probes deaths of two patients on Lilly schizophrenia drug June 18, 2013
    (Reuters) - The Food and Drug Administration is investigating the cases of two individuals who died after injections with Eli Lilly and Co's long-acting treatment for schizophrenia, Zyprexa Relprevv. […]
  • AstraZeneca turnaround is 3-4 year journey, says CEO June 18, 2013
    LONDON (Reuters) - Turning around drugmaker AstraZeneca will be a long haul, with a strategy of revamping research and boosting acquisitions set to take up to four years to pay off, its chief executive said on Tuesday. […]
  • GSK negotiating $1 billion sale of thrombosis drugs to Aspen June 18, 2013
    LONDON (Reuters) - GlaxoSmithKline is discussing the sale of its thrombosis drug brands Arixtra and Fraxiparine, along with a related French factory, to Aspen Pharmacare in a deal that could be worth some $1 billion. […]
  • WHO urges tougher food marketing rules to curb childhood obesity June 18, 2013
    LONDON (Reuters) - The marketing of unhealthy foods to children has proven "disastrously effective", driving obesity by using cheap social media channels to promote fat-, salt- and sugar-laden foods, the World Health Organisation's Europe office said on Tuesday. […]
  • AstraZeneca picks site for new global home in Cambridge June 18, 2013
    LONDON (Reuters) - AstraZeneca has chosen a science park on the southern outskirts of Cambridge, England, next to the world-renowned Addenbrooke's Hospital, for its new $500 million global headquarters and research center. […]
  • J&J in $1 billion deal to bolster prostate-cancer focus June 17, 2013
    (Reuters) - Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand. […]
  • Medtronic bone graft has limited benefit, may cause harm: reviews June 17, 2013
    (Reuters) - Two long-awaited independent reviews of a controversial Medtronic Inc bone growth product show it works as well as traditional bone grafts taken from patients, but it may not be as safe. […]
  • Wait-and-see may be best for early prostate cancer June 17, 2013
    NEW YORK (Reuters Health) - Watching and routinely examining men with early, slow-growing prostate cancer is more effective and cheaper than sending them to surgery or radiation right away, according to a new study. […]
  • Saudi Arabia says MERS coronavirus kills four more June 17, 2013
    DUBAI (Reuters) - Four more people have died and three more have fallen ill in Saudi Arabia from the new SARS-like coronavirus MERS-CoV, the Saudi Health Ministry said on Monday. […]
  • Blood tests could detect sexually-transmitted oral cancers June 17, 2013
    LONDON (Reuters) - Antibodies to a high-risk type of a virus that causes mouth and throat cancers when transmitted via oral sex can be detected in blood tests many years before onset of the disease, according to a World Health Organisation-led team of researchers. […]

The Posts On Health At Twitter